Home
/
NATIONAL HEALTH INVESTORS INC
/
Financials
/
Quarterly
NATIONAL HEALTH INVESTORS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NATIONAL HEALTH INVESTORS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$89.85M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$90.66M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$89.30M
May 5, 2025
Q3
2025
Sep 30, 2024
$82.94M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$84.97M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$81.51M
May 5, 2025
Q3
2024
Sep 30, 2023
$80.11M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$77.88M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$82.39M
May 6, 2024
Q3
2023
Sep 30, 2022
$76.30M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$59.90M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$71.33M
May 9, 2023
Q3
2022
Sep 30, 2021
$73.83M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$74.33M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$80.89M
May 9, 2022
Q3
2019
Sep 30, 2019
$81.68M
Nov 7, 2019
Q2
2019
Jun 30, 2019
$78.10M
Aug 8, 2019
Q1
2019
Mar 31, 2019
$76.11M
May 7, 2019
Q3
2019
Sep 30, 2018
$74.92M
Nov 7, 2019
Q2
2019
Jun 30, 2018
$72.96M
Aug 8, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.18M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$14.22M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$13.94M
May 5, 2025
Q3
2025
Sep 30, 2024
$13.77M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$13.39M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$13.26M
May 5, 2025
Q3
2024
Sep 30, 2023
$12.37M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$11.79M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$11.70M
May 6, 2024
Q3
2023
Sep 30, 2022
$12.01M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$11.99M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$0
May 9, 2023
Q3
2022
Sep 30, 2021
$0
Nov 8, 2022
Q2
2022
Jun 30, 2021
$0
Aug 8, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$32.86M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$36.99M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$34.17M
May 5, 2025
Q3
2025
Sep 30, 2024
$28.54M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$35.26M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$30.95M
May 5, 2025
Q3
2024
Sep 30, 2023
$29.35M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$39.78M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$34.48M
May 6, 2024
Q3
2023
Sep 30, 2022
$34.47M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$21.67M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$8.40M
May 9, 2023
Q3
2022
Sep 30, 2021
$30.81M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$39.18M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$35.33M
May 9, 2022
Q3
2019
Sep 30, 2019
$42.76M
Nov 7, 2019
Q2
2019
Jun 30, 2019
$39.98M
Aug 8, 2019
Q1
2019
Mar 31, 2019
$35.68M
May 7, 2019
Q3
2019
Sep 30, 2018
$40.98M
Nov 7, 2019
Q2
2019
Jun 30, 2018
$37.84M
Aug 8, 2019
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$42.76M
Nov 7, 2019
Q2
2019
Jun 30, 2019
$39.98M
Aug 8, 2019
Q1
2019
Mar 31, 2019
$35.68M
May 7, 2019
Q3
2019
Sep 30, 2018
$40.98M
Nov 7, 2019
Q2
2019
Jun 30, 2018
$37.84M
Aug 8, 2019
Q1
2019
Mar 31, 2018
$39.17M
May 7, 2019
Q3
2018
Sep 30, 2017
$39.59M
Nov 6, 2018
Q2
2018
Jun 30, 2017
$38.34M
Aug 7, 2018
Q1
2018
Mar 31, 2017
$34.14M
May 8, 2018
Q3
2017
Sep 30, 2016
$33.47M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$18.60M
Aug 9, 2017
Q1
2017
Mar 31, 2016
$31.69M
May 9, 2017
Q3
2014
Sep 30, 2014
$25.52M
Nov 3, 2014
Q2
2014
Jun 30, 2014
$25.58M
Aug 4, 2014
Q1
2014
Mar 31, 2014
$23.86M
May 8, 2014
Q3
2014
Sep 30, 2013
$22.34M
Nov 3, 2014
Q2
2014
Jun 30, 2013
$18.48M
Aug 4, 2014
Q1
2014
Mar 31, 2013
$14.23M
May 8, 2014
Q3
2013
Sep 30, 2012
$13.28M
Nov 4, 2013
Q2
2013
Jun 30, 2012
$15.86M
Aug 6, 2013